<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2019-2-106-112</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-2862</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БРОНХОПУЛЬМОНОЛОГИЯ, ЛОР</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BRONCHOPULMONOLOGY, ENT</subject></subj-group></article-categories><title-group><article-title>Оптимальный выбор анальгетического и жаропонижающего препарата в педиатрической практике</article-title><trans-title-group xml:lang="en"><trans-title>The optimal choice of an analgesic and antipyretic drug in paediatric practice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дроздов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Drozdov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дроздов Владимир Николаевич – доктор медицинских наук, профессор кафедры клинической фармакологии и пропедевтики внутренних болезней</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2 </p></bio><bio xml:lang="en"><p>Drozdov Vladimir Nikolaevich – Dr. of Sci. (Med.), Professor of the Chair of Clinical Pharmacology and Propaedeutics of Internal Diseases</p><p>8, Trubetskaya Street, Moscow, 119991, p. 2 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Багдасарян</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bagdasaryan</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Багдасарян Алина Арсеновна – врач ординатор кафедры клинической фармакологии и пропедевтики внутренних болезней</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2 </p></bio><bio xml:lang="en"><p>Bagdasaryan Alina Arsenovna – Dr. of Sci. (Med.), Resident Physician of the Chair of Clinical Pharmacology and Propaedeutics of Internal Diseases</p><p>8, Trubetskaya Street, Moscow, 119991, p. 2 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сереброва</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Serebrova</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сереброва Светлана Юрьевна – доктор медицинских наук, профессор кафедры клинической фармакологии и пропедевтики внутренних болезней Федерального государственного автономного образовательного учреждения высшего образования «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский университет); Федеральное государственное бюджетное учреждение «Научный центр экспертизы средств медицинского применения» Министерства здравоохранения Российской Федерации</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2, </p><p>127051, Москва, Петровский бульвар, д. 8, стр. 2 </p></bio><bio xml:lang="en"><p>Serebrova Svetlana Yurievna – Dr. of Sci. (Med.), Professor of the Chair of Clinical Pharmacology and Propaedeutics of Internal Diseases, Federal State Autonomous Educational Institution of Higher Education «Sechenov First Moscow State Medical University» of the Ministry of Heath of the Russian Federation (Sechenov University); Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation</p><p>8, Trubetskaya Street, Moscow, 119991, p. 2, 127051, Moscow, Petrovsky Bulvar, 8, Bldg. 2 </p></bio><email xlink:type="simple">svetaserebrova@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муратов</surname><given-names>К. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Muratov</surname><given-names>K. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Муратов Кирилл Михайлович – врач ординатор кафедры клинической фармакологии и пропедевтики внутренних болезней</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2 </p></bio><bio xml:lang="en"><p>Muratov Kirill Mikhailovich – Resident Physician of the Chair of Clinical Pharmacology and Propaedeutics of Internal Diseases</p><p>8, Trubetskaya Street, Moscow, 119991, p. 2 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стародубцев</surname><given-names>А. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Starodubtsev</surname><given-names>A. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Стародубцев Алексей Константинович – доктор медицинских наук, профессор кафедры клинической фармакологии и пропедевтики внутренних болезней</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2 </p></bio><bio xml:lang="en"><p>Starodubtsev Alexei Konstantinovich – Dr. of Sci. (Med.), Professor of the Chair of Clinical Pharmacology and Propaedeutics of Internal Diseases</p><p>8, Trubetskaya Street, Moscow, 119991, p. 2 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бондаренко</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bondarenko</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бондаренко Дмитрий Александрович – студент кафедры клинической фармакологии и пропедевтики внутренних болезней</p><p>119991, Москва, ул. Трубецкая, д. 8, стр. 2 </p></bio><bio xml:lang="en"><p>Bondarenko Dmitri Alexandrovich – student of the Chair of Clinical Pharmacology and Propaedeutics of Internal Diseases</p><p>8, Trubetskaya Street, Moscow, 119991, p. 2 </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Федеральное государственное автономное образовательное учреждение высшего образования «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский университет);&#13;
Федеральное государственное бюджетное учреждение «Научный центр экспертизы средств медицинского применения» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University);&#13;
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>13</day><month>02</month><year>2019</year></pub-date><volume>0</volume><issue>2</issue><fpage>106</fpage><lpage>112</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Дроздов В.Н., Багдасарян А.А., Сереброва С.Ю., Муратов К.М., Стародубцев А.К., Бондаренко Д.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Дроздов В.Н., Багдасарян А.А., Сереброва С.Ю., Муратов К.М., Стародубцев А.К., Бондаренко Д.А.</copyright-holder><copyright-holder xml:lang="en">Drozdov V.N., Bagdasaryan A.A., Serebrova S.Y., Muratov K.M., Starodubtsev A.K., Bondarenko D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/2862">https://www.med-sovet.pro/jour/article/view/2862</self-uri><abstract><p>Одним из наиболее распространенных поводов для обращения к врачу-педиатру является возникновение лихорадки и болевого синдрома у детей. Для их купирования широко используются нестероидные противовоспалительные лекарственные препараты (НПВП), механизм действия которых заключается в ингибировании фермента циклооксигеназы (ЦОГ). Одним из препаратов, ингибирующих ЦОГ, является парацетамол, который реализует свой фармакодинамический эффект в центральной нервной системе, тем самым оказывая жаропонижающий и обезболивающий эффекты, но для купирования воспаления он оказывается неэффективным. Среди показаний к применению Эффералгана, действующим веществом которого является парацетамол, у детей выделяют часто встречающиеся состояния, такие как лихорадка и болевой синдром легкой и средней интенсивности. У детей наиболее часто применяются раствор и ректальные суппозитории Эффералгана, т. к. допустимо применение этих лекарственных форм при достижении ребенком возраста 1 и 3 мес. соответственно. Дозировка препарата зависит от массы тела. Следует помнить, что купирование лихорадки или болевого синдрома – симптоматическое лечение, поэтому при их появлении требуется консультация врача для тщательного выявления возможной причины и выбора соответствующей терапии.</p></abstract><trans-abstract xml:lang="en"><p>Onset of fever and pain syndrome in children is one of the most frequent reasons parents take their children to a paediatrician. Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used to relieve such symptoms. The mechanism of action of NSAIDs is to inhibit the activity of the enzyme called cyclooxygenase (COX). Paracetamol, one of the drugs that inhibit COX, exerts its pharmacodynamic effect in the central nervous system, thereby providing antipyretic and analgesic effects, but it is ineffective in stopping inflammation. Such common conditions in children as fever and pain syndrome of mild to medium intensity are among the indications for use of Efferalgan containing paracetamol as an active ingredient. Solution and rectal suppositories are the most commonly used dosage forms of Efferalgan in children, as these dosage forms can be used, when the child reaches 1 and 3 months of age, respectively. The correct dose of paracetamol for a child depends on their weight. It should be remembered that the relief of a fever or pain syndrome is a symptomatic treatment. Therefore, if they appear, you should visit a doctor to identify carefully the possible cause and select the appropriate therapy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>лихорадка у детей</kwd><kwd>болевой синдром у детей</kwd><kwd>нестероидные противовоспалительные препараты</kwd><kwd>парацетамол</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fever in children</kwd><kwd>pain syndrome in children</kwd><kwd>nonsteroidal anti-inflammatory drugs</kwd><kwd>paracetamol</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Walter E.J., Hanna-Jumma S., Carraretto M., Forni L. The pathophysiological basis and consequences of fever. Critical Care. 2016;20:200. doi: 10.1186/s13054-016-1375-5.</mixed-citation><mixed-citation xml:lang="en">Walter E.J., Hanna-Jumma S., Carraretto M., Forni L. The pathophysiological basis and consequences of fever. Critical Care. 2016;20:200. doi: 10.1186/s13054-016-1375-5.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001; 294: 1871–1875. doi: 10.1126/science.294.5548.1871.</mixed-citation><mixed-citation xml:lang="en">Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001; 294: 1871–1875. doi: 10.1126/science.294.5548.1871.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chandrasekharan N.V., Dai Hu, Roos K.L., Evanson N.K., Tomsik J., Elton T.S., and Simmons D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21): 13926–13931. Published online 2002 Sep 19. doi: 10.1073/pnas.162468699.</mixed-citation><mixed-citation xml:lang="en">Chandrasekharan N.V., Dai Hu, Roos K.L., Evanson N.K., Tomsik J., Elton T.S., and Simmons D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21): 13926–13931. Published online 2002 Sep 19. doi: 10.1073/pnas.162468699.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kumpulainen E., Kokki H., Halonen T., Heikkinen M., Savolainen J., Laisalmi M. Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluid of children after intravenous administration. Pediatrics. 2007;119:766– 771. doi: 10.1542/peds.2006-3378.</mixed-citation><mixed-citation xml:lang="en">Kumpulainen E., Kokki H., Halonen T., Heikkinen M., Savolainen J., Laisalmi M. Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluid of children after intravenous administration. Pediatrics. 2007;119:766– 771. doi: 10.1542/peds.2006-3378.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson B.J., Holford N.H., Woollard G.A., Chan P.L. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol. 1998;46:237–243. doi: 10.1046/j.1365-2125.1998.00780.x.</mixed-citation><mixed-citation xml:lang="en">Anderson B.J., Holford N.H., Woollard G.A., Chan P.L. Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol. 1998;46:237–243. doi: 10.1046/j.1365-2125.1998.00780.x.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Flower R.J., Vane J.R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972;240:410–411. [PubMed: 4564318].</mixed-citation><mixed-citation xml:lang="en">Flower R.J., Vane J.R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972;240:410–411. [PubMed: 4564318].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Министерство здравоохранения Российской Федерации. Острая респираторная инфекция (ОРВИ) у детей. 2016 год.</mixed-citation><mixed-citation xml:lang="en">Ministry of Health of the Russian Federation. Acute respiratory infection (ARVI) in children. 2016. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Здравоохранение в России. 2015: Стат.сб. Росстат. М., 2015. 174 с.</mixed-citation><mixed-citation xml:lang="en">Healthcare in Russia. 2015: Rosstat statistics digest. M., 2015. 174 p. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">The management of fever in children with acute respiratory infection in developing countries. Geneva: World Health Organization, WHO/ ARI/93.30; 1993.</mixed-citation><mixed-citation xml:lang="en">The management of fever in children with acute respiratory infection in developing countries. Geneva: World Health Organization, WHO/ ARI/93.30; 1993.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Абузарова Г.Р., Невзорова Д.В., Кумирова Э.В., Савва Н.Н., Арутюнов Г.П., Багненко С.Ф., Данилов Ал.Б., Данилов А.Б., Куняева Т.А., Николаева Н.М., Молчанов И.В., Падалкин В.П., Поляков В.Г., Пчелинцев М.В., Степаненко С.М. Обезболивание взрослых и детей при оказании медицинской помощи. Методические рекомендации. ФГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России. М., 2016. 94 с.</mixed-citation><mixed-citation xml:lang="en">Abuzarova G.R., Nevzorova D.V., Kumirova E.V., Savva N.N., Arutyunov G.P., Bagnenko S.F., Danilov Al.B., Danilov AB, Kunyaeva T .A., Nikolaeva N.M., Molchanov I.V., Padalkin V.P., Polyakov V.G., Pchelintsev M.V., Stepanenko S.M. Guidelines for the provision of anaesthesia services to adults and children. Pirogov National Research Medical University. M., 2016. 94 p. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Jóźwiak-Bebenista M., Nowak J.Z. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014 JanFeb;71(1):11-23.</mixed-citation><mixed-citation xml:lang="en">Jóźwiak-Bebenista M., Nowak J.Z. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014 JanFeb;71(1):11-23.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Prescott L.F. Paracetamol: past, present, and future. Am J Ther. 2000 Mar;7(2):143-7.</mixed-citation><mixed-citation xml:lang="en">Prescott L.F. Paracetamol: past, present, and future. Am J Ther. 2000 Mar;7(2):143-7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ghanem C.I., Pérez María J., Manautou J.E., and Mottino A.D. Acetaminofen; from liver to brain: new insights into drug pharmacological action and toxicity. Pharmacol Res. 2016 July;109:119– 131. doi:10.1016/j.phrs.2016.02.020.</mixed-citation><mixed-citation xml:lang="en">Ghanem C.I., Pérez María J., Manautou J.E., and Mottino A.D. Acetaminofen; from liver to brain: new insights into drug pharmacological action and toxicity. Pharmacol Res. 2016 July;109:119– 131. doi:10.1016/j.phrs.2016.02.020.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mitchell J.R., Jollow D.J., Potter W.Z., Gillette J.R., Brodie B.B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973;187:211–217. [PubMed: 4746329] (In Russ)..</mixed-citation><mixed-citation xml:lang="en">Mitchell J.R., Jollow D.J., Potter W.Z., Gillette J.R., Brodie B.B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973;187:211–217. [PubMed: 4746329] (In Russ)..</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hay A.D., Redmond N.M., Costelloe C., Montgomery A.A., Fletcher M., Hollinghurst S., Peters T.J. Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial. Health Technol Assess. 2009 May;13(27):iii-iv, ix-x, 1-163. doi: 10.3310/hta13270.</mixed-citation><mixed-citation xml:lang="en">Hay A.D., Redmond N.M., Costelloe C., Montgomery A.A., Fletcher M., Hollinghurst S., Peters T.J. Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial. Health Technol Assess. 2009 May;13(27):iii-iv, ix-x, 1-163. doi: 10.3310/hta13270.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kramer M.S., Naimark L.E., Roberts-Bräuer R., McDougall A., Leduc D.G. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet. 1991 Mar 9;337(8741):591-4.</mixed-citation><mixed-citation xml:lang="en">Kramer M.S., Naimark L.E., Roberts-Bräuer R., McDougall A., Leduc D.G. Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet. 1991 Mar 9;337(8741):591-4.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Southey E.R., Soares-Weiser K., Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009 Sep;25(9):2207-22. doi: 10.1185/03007990903116255.</mixed-citation><mixed-citation xml:lang="en">Southey E.R., Soares-Weiser K., Kleijnen J. Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin. 2009 Sep;25(9):2207-22. doi: 10.1185/03007990903116255.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kanabar D.J.. A clinical and safety review of paracetamol and ibuprofen in children. Inflammopharmacology. 2017 Feb 6;25(1):1-9. Published 2017 Jan 6. doi: 10.1007/s10787-016-0302-3.</mixed-citation><mixed-citation xml:lang="en">Kanabar D.J.. A clinical and safety review of paracetamol and ibuprofen in children. Inflammopharmacology. 2017 Feb 6;25(1):1-9. Published 2017 Jan 6. doi: 10.1007/s10787-016-0302-3.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">de Martino M., Chiarugi A. Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management. Pain Ther. 2015;4:149-168. doi: 10.1007/s40122-015-0040-z.</mixed-citation><mixed-citation xml:lang="en">de Martino M., Chiarugi A. Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management. Pain Ther. 2015;4:149-168. doi: 10.1007/s40122-015-0040-z.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
